Literature DB >> 6544901

Clinical DNA flow cytometry.

B Tribukait.   

Abstract

Modal DNA values of tumours from various sites may exhibit (1) a diploid-near diploid distribution, (2) an exponential distribution in the tetraploid to triploid range, or (3) a log-normal distribution in the triploid to tetraploid range. Examples of these various types of distribution are non-Hodgkin's lymphoma (1), aneuploid prostate carcinoma (2), aneuploid colon, breast, cervix and testicular carcinomas (3). These differences indicate dissimilarities in tumour development. In aneuploid tumours from the same site both tetraploid exponential and triploid-tetraploid log-normal distributions may occur. In bladder carcinoma these are related to grade. Modal DNA values in tumours are 10% higher than would be expected from modal chromosome numbers. This difference seems not to be due to a relative increase in large-sized chromosomes or due to technical shortcomings. Chromosome studies also show the possibility of the existence of near diploid malignant cells in grossly aneuploid tumours. Modal DNA values are connected with functional tumour properties by the proportion of S-phase cells. The significance of the latter is exemplified by follow-up of patients with bladder and cervix carcinoma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6544901     DOI: 10.1007/bf02934525

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  27 in total

1.  Cytological diagnosis of prostatic tumours by transrectal aspiration biopsy: a preliminary report.

Authors:  S FRANZEN; G GIERTZ; J ZAJICEK
Journal:  Br J Urol       Date:  1960-06

2.  Chromosomal evolution in the Ehrlich-Lettré complex of hyperdiploid mouse ascites tumors: results from seven laboratory strains.

Authors:  K Nielsén
Journal:  Hereditas       Date:  1976       Impact factor: 3.271

Review 3.  Flow cytometry in clinical cancer research.

Authors:  B Barlogie; M N Raber; J Schumann; T S Johnson; B Drewinko; D E Swartzendruber; W Göhde; M Andreeff; E J Freireich
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

4.  Analysis of cell flow and cell loss following X-irradiation using sequential investigation of the total number of cells in the various parts of the cell cycle.

Authors:  S Skog; B Tribukait
Journal:  Cell Tissue Kinet       Date:  1985-07

5.  Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.

Authors:  S B Ewers; E Långström; B Baldetorp; D Killander
Journal:  Cytometry       Date:  1984-07

6.  Chromosomal and DNA patterns in transitional cell bladder carcinoma. A comparative cytogenetic and flow-cytofluorometric DNA study.

Authors:  H Wijkström; I Granberg-Ohman; B Tribukait
Journal:  Cancer       Date:  1984-04-15       Impact factor: 6.860

7.  Influence of cellular DNA content on survival in advanced ovarian cancer.

Authors:  M L Friedlander; D W Hedley; I W Taylor; P Russell; A S Coates; M H Tattersall
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

8.  Flow DNA analysis of primary bone tumors. Relationship between cellular DNA content and histopathologic classification.

Authors:  A Kreicbergs; C Silvferswärd; B Tribukait
Journal:  Cancer       Date:  1984-01-01       Impact factor: 6.860

9.  The influence of age on the DNA ploidy levels of breast tumours.

Authors:  I W Taylor; E A Musgrove; M L Friedlander; M S Foo; D W Hedley
Journal:  Eur J Cancer Clin Oncol       Date:  1983-05

10.  Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases.

Authors:  N B Atkin; R Kay
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

View more
  8 in total

1.  Co-existence of two aneuploid stemlines in benign adenomas. A report of three cases with stemline heterogeneity.

Authors:  H Joensuu; P J Klemi; K A Alanen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

2.  Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development?

Authors:  R Löfberg; B Tribukait; A Ost; O Broström; H Reichard
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

3.  Independent clinical and flow cytometric prognostic factors for the survival of patients with stage I gastric cancer.

Authors:  Y Yonemura; S Ohoyama; H Kimura; H Matumoto; I Ninomiya; T Kosaka; A Yamaguchi; K Miwa; I Miyazaki
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

4.  Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas.

Authors:  G Lindmark; B Glimelius; L Påhlman; P Enblad
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

5.  A comparison of static cytofluorometry and flow cytometry for the estimation of ploidy and DNA replication in human breast cancer.

Authors:  O Stål; C Klintenberg; G Franzen; B Risberg; S Arvidsson; K Bjelkenkrantz; L Skoog; B Nordenskjöld
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

6.  DNA aneuploidy in adenomas of endocrine organs.

Authors:  H Joensuu; P J Klemi
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

7.  Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.

Authors:  B S Bolger; T G Cooke; R P Symonds; A B MacLean; P D Stanton
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

8.  Individual karyotypes at the origins of cervical carcinomas.

Authors:  Amanda McCormack; Jiang Lan Fan; Max Duesberg; Mathew Bloomfield; Christian Fiala; Peter Duesberg
Journal:  Mol Cytogenet       Date:  2013-10-17       Impact factor: 2.009

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.